4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-22-004988
CHIEF EXECUTIVE OFFICER acquired 100,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Singh Shawn CHIEF EXECUTIVE OFFICER | 2022-05-12 | Option exercise | +100,000 | $1.00 | $100,000 | 148,998 | D |
| Derivatives | |||||||
| Singh Shawn CHIEF EXECUTIVE OFFICER | 2022-05-12 | Option exercise · Stock Option (Right to Buy) | −100,000 | 70,000 | D | ||
Loading xslF345X03/form4-05162022_100519.xml…